Steven P. Levine, MD

home / authors / steven-p-levine

Dr Levine is senior vice president of Patient Access and Medical Affairs at Compass Pathways and chairman at Heading Health.

Articles

ACNP Meeting Highlights Bright Future for Psychiatry

ACNP Meeting Highlights Bright Future for Psychiatry

Steven P. Levine, MD;Heidi Anne Duerr, MPH
December 10th 2024

In highlighting recent advances and fostering collaboration and networking, the ACNP Annual Meeting helps usher in 2025 with hope and positivity.

treatment resistant depression

Defining Treatment-Resistant Depression

Carl D. Marci, MD;Steven P. Levine, MD
May 21st 2023

Does treatment-resistant depression exist? These 2023 APA Annual Meeting panelists discuss definitions in this exclusive video.

Integrated Care and Treatment-Resistant Depression

Integrated Care and Treatment-Resistant Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Electroconvulsive Therapy for Depression

Electroconvulsive Therapy for Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Traditional Classes of Antidepressant Therapies

Traditional Classes of Antidepressant Therapies

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Frontline Psychotherapy for Depression

Frontline Psychotherapy for Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Treatment-Resistant Depression: Financial Support for Esketamine Therapy

Treatment-Resistant Depression: Financial Support for Esketamine Therapy

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Incorporating Esketamine into Practice for Treatment-Resistant Depression

Incorporating Esketamine into Practice for Treatment-Resistant Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Getting Certified to Administer Esketamine for Treatment-Resistant Depression

Getting Certified to Administer Esketamine for Treatment-Resistant Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Treatment-Resistant Depression: Administering Esketamine to Patients

Treatment-Resistant Depression: Administering Esketamine to Patients

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
REMS Safety Program for Esketamine in Treatment-Resistant Depression

REMS Safety Program for Esketamine in Treatment-Resistant Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Response to Esketamine Therapy for Treatment-Resistant Depression

Response to Esketamine Therapy for Treatment-Resistant Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Monitoring Patients on Esketamine Therapy for Treatment-Resistant Depression

Monitoring Patients on Esketamine Therapy for Treatment-Resistant Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Esketamine for Treatment-Resistant Depression: Patient Selection Criteria

Esketamine for Treatment-Resistant Depression: Patient Selection Criteria

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Intranasal Esketamine for Treatment-Resistant Depression

Intranasal Esketamine for Treatment-Resistant Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Current Guidelines for Managing Treatment-Resistant Depression

Current Guidelines for Managing Treatment-Resistant Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
IV Ketamine for Treatment-Resistant Depression

IV Ketamine for Treatment-Resistant Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021
Prevalence of Treatment-Resistant Depression

Prevalence of Treatment-Resistant Depression

Steven P. Levine, MD;Angelos Halaris, MD, PhD, APA, ACNP, CINP;Lisa Harding, MD;Patricia Ares-Romero, MD, FASAM
July 15th 2021

Latest Updated Articles

winter
Published: December 20th 2024 | Updated: December 22nd 2024
Poll: How Are You Handling the Holidays as a Clinician?
Mini Quiz: Treatment for Pedophilia?
Published: March 19th 2021 | Updated: December 22nd 2024
Mini Quiz: Treatment for Pedophilia?
Mini Quiz: Medical Catatonia
Published: May 12th 2017 | Updated: December 22nd 2024
Mini Quiz: Medical Catatonia
Mini Quiz: Methods of Suicide
Published: January 21st 2016 | Updated: December 22nd 2024
Mini Quiz: Methods of Suicide
Mini Quiz: Integrative Child Psychiatry
Published: April 5th 2017 | Updated: December 22nd 2024
Mini Quiz: Integrative Child Psychiatry
Love and Rorschach: A Valentine's Day Quiz
Published: February 14th 2019 | Updated: December 22nd 2024
Love and Rorschach: A Valentine's Day Quiz
© 2024 MJH Life Sciences

All rights reserved.